Clinical Trial: A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies

U.S., Oct. 7 -- ClinicalTrials.gov registry received information related to the study (NCT07207707) titled 'A Study to Investigate the Safety and Efficacy of KQB548 in Participants With Advanced Solid Malignancies' on Sept. 03.

Brief Summary: The goal of this trial is to learn if KQB548 works to treat patients with advanced solid malignancies with a KRAS G12D mutation. It will also learn about the safety of KQB548. The main questions it aims to answer are:

* What is the safe dose of KQB548?

* Does KQB548 decrease the size of the tumor?

* What happens to KQB548 in the body?

Study Start Date: Sept. 16

Study Type: INTERVENTIONAL

Condition: Solid Tumor Malignancies

Intervention: DRUG: KQB548

Oral KQB548

Recruitment Status: RECRUITIN...